Clinicohematological Profile of Pancytopenia Patients in Tertiary Care Hospital
Introduction: Pancytopenia is a common hematological problem characterized by anemia, leucopenia, and thrombocytopenia. It can be a serious and life-threatening illness. Aim: The objective of this study is to study the clinical presentation and hematological profile in pancytopenia patients. Materia...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2025-05-01
|
| Series: | Journal of Pharmacy and Bioallied Sciences |
| Subjects: | |
| Online Access: | https://journals.lww.com/10.4103/jpbs.jpbs_631_25 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Introduction:
Pancytopenia is a common hematological problem characterized by anemia, leucopenia, and thrombocytopenia. It can be a serious and life-threatening illness.
Aim:
The objective of this study is to study the clinical presentation and hematological profile in pancytopenia patients.
Material and Methods:
The prospective study was done on 50 pancytopenia patients in a tertiary care hospital and the hematological profile was studied. All the cases with hemoglobin [Hb] less than 13 gm/dL in male and female <12 g/dL, total leukocyte count [TLC] less than 4000/cumm, and platelet count less than 150,000/cumm were included in the study.
Result:
It was observed that the majority of the cases had hypercellular marrow [40%], 34% normocellular, and 26% hypocellular marrow. Males [52%] were affected more as compared to females [48%]. Megaloblastic erythroid hyperplasia was found to be the commonest cause for pancytopenia [40%], followed by normoblastic erythroid hyperplasia [5.71%], non-Hodgkin lymphoma [11.42%], acute leukemia [2.85%], MDS [2.85%], malaria [2.85%], hypersplenism 2.85%], lymphoid malignancy [2.85%], focal gelatinous [2.85%], AML [2.85%], megakaryocytic thrombocytopenia [2.85%], and plasma cell myeloma [2.85%].
Conclusion:
It was concluded that the detailed hematological investigations, a thorough clinical examination with hematological studies and bone marrow study is important for understanding the disease process and diagnosing the causes of pancytopenia. |
|---|---|
| ISSN: | 0976-4879 0975-7406 |